Nature Communications (Jan 2023)

Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus

  • Anna M. Sigmund,
  • Markus Winkler,
  • Sophia Engelmayer,
  • Daniela Kugelmann,
  • Desalegn T. Egu,
  • Letyfee S. Steinert,
  • Michael Fuchs,
  • Matthias Hiermair,
  • Mariya Y. Radeva,
  • Franziska C. Bayerbach,
  • Elisabeth Butz,
  • Stefan Kotschi,
  • Christoph Hudemann,
  • Michael Hertl,
  • Sunil Yeruva,
  • Enno Schmidt,
  • Amir S. Yazdi,
  • Kamran Ghoreschi,
  • Franziska Vielmuth,
  • Jens Waschke

DOI
https://doi.org/10.1038/s41467-022-35741-0
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 17

Abstract

Read online

Pemphigus vulgaris is a life-threatening blistering skin disease caused by autoantibodies which destabilize cell adhesion of keratinocytes. The phosphodiesterase 4 inhibitor apremilast prevents skin blistering by stabilizing the keratin filament anchorage of desmosomes.